134 results on '"Rivlin J"'
Search Results
2. Serum CA 19–9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests
3. A NOVEL INTERPLAY BETWEEN THE NMD MECHANISM AND ER STRESS RESPONSE AFFECTING CELLULAR HOMEOSTASIS UNDER NORMAL CONDITIONS AND IN HUMAN DISEASES: 163
4. PTC124 ACTIVITY IN CF PATIENTS CARRYING STOP MUTATIONS: INTERIM RESULTS OF A PHASE 2 STUDY: 242*
5. Trampoline Use as Physiotherapy for Cystic Fibrosis Patients
6. Chronic Lung Disease and Cystic Fibrosis Phenotype in Prolidase Deficiency: A Newly Recognized Association
7. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.
8. Media Type Registrations for the Open eBook Publication Structure (OEBPS) Package File (OPF)
9. Bill Forms in the Munich Talmud Manuscript / טופסי שטרות בש"ס כתב-יד מינכן
10. Furqan (ألفرقان) in the Qur'an / הפרקאן (ألفرقان) בקוראן
11. The frequency of the ΔF508 mutation on cystic fibrosis chromosomes in Israeli families: correlation to CF haplotypes in Jewish communities and Arabs
12. ePS06.7 Factors associated with failure to eradicate first or newly acquired Pseudomonas aeruginosa in patients with CF
13. 297 Arab cystic fibrosis patients in Israel
14. 147 Causes of failure to eradicate Pseudomonas aeruginosa in patients with CF
15. 301 Our adaptive means to encourage treatment adherence in CF patients
16. Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
17. Nasal potential difference in non classic cystic fibrosis – long term follow up
18. 41* PTC124 activity in CF patients carrying stop mutations: results of a phase 2 study
19. Plenty of challenges remain GOLDMAN SACHS:
20. Role of Hydrogen Peroxide in Sperm Capacitation and Acrosome Reaction1
21. Trampoline use as physiotherapy for cystic fibrosis patients
22. Serum CA 19?9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests
23. Nasal potential difference measurements in patients with atypical cystic fibrosis
24. Adhesion-related abdominal wall varices: demonstration by color Doppler sonography.
25. CLINICAL AND GENETIC RISK FACTORS FOR THE DEVELOPMENT OF LIVER DISEASE IN CYSTIC FIBROSIS.
26. Similar levels of mRNA from the W1282X and the delta F508 cystic fibrosis alleles, in nasal epithelial cells.
27. Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study.
28. Numerical solution of the equations of compressible flow by a transport method
29. Suppressor T-lymphocyte activity in wheezy children with and without treatment by hyposensitization.
30. Rate Studies of Viscose Coagulation and Regeneration.
31. The errors in surface runoff prediction by neglecting the relationship between infiltration rate and overland flow depth
32. Knowledge Based Consultation for Finite Element Structural Analysis.
33. Upper Airway Morphology in Patients with Idiopathic Obstructive Sleep Apnea
34. The Effect of Oxygen on Sleep, Blood Gases, and Ventilation in Cystic Fibrosis1,2
35. 239. Topical gentamicin rectifies abnormal nasal PD measurements in CF patients carrying stop mutations
36. Effect of administration technique on bronchodilator response to fenoterol in a metered-dose inhaler
37. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.
38. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
39. Disparities in postoperative complications and perioperative events based on insurance status following elective spine surgery: A systematic review and meta-analysis.
40. Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia.
41. Mutation of serine/threonine protein kinase 36 (STK36) causes primary ciliary dyskinesia with a central pair defect.
42. Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening.
43. Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.
44. Primary ciliary dyskinesia in Israel: Prevalence, clinical features, current diagnosis and management practices.
45. Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities.
46. Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes.
47. [CYSTIC FIBROSIS SURVIVAL TRENDS IN CARMEL MEDICAL CENTER].
48. Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.
49. The unfolded protein response affects readthrough of premature termination codons.
50. Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.